• Explore /
  • Poster
  • / NCI 9448: Phase I study of trametinib in combination with chemoradiation for KRAS-mutant non-small cell lung cancer.

NCI 9448: Phase I study of trametinib in combination with chemoradiation for KRAS-mutant non-small cell lung cancer.

Abstract Poster

Authors

null

Steven H. Lin

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Steven H. Lin , Isabel Mok , David Leos , Manolo G Pasia , Peter F. Thall , Heather Y. Lin , Meng XU Welliver , Miguel Angel Villalona-Calero , James C. Yao , Funda Meric-Bernstam , Ritsuko Komaki , Helen X. Chen , George R. Blumenschein Jr.

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Local-Regional Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT01912625

Citation

J Clin Oncol 33, 2015 (suppl; abstr TPS7585)

DOI

10.1200/jco.2015.33.15_suppl.tps7585

Abstract #

TPS7585

Poster Bd #

332a

Abstract Disclosures

Similar Posters

First Author: Nabiel Ali Mir

First Author: Hossein Borghaei

First Author: Richard Francis Dunne

First Author: Salma K. Jabbour